Literature DB >> 20204300

The prognostic value of cadherin switch in bladder cancer.

Tobias Jäger1, Markus Becker, Andreas Eisenhardt, Derya Tilki, Martin Tötsch, Kurt W Schmid, Imre Romics, Herbert Rübben, Süleyman Ergün, Tibor Szarvas.   

Abstract

Loss of E-cadherin expression and gain of N-cadherin expression ('cadherin switch') is shown to be characteristic in epithelial to mesenchymal transition (EMT), a mechanism associated with cancer progression. Furthermore, the prognostic role of P-cadherin in different cancers is controversial. The aim of this study was to evaluate the prognostic significance of 'cadherin switch' on the gene expression level in bladder cancer. Frozen tissue samples of 181 bladder cancer patients and 7 control individuals were analyzed by quantitative real-time PCR. Kaplan-Meier log-rank test and Cox univariate and multivariate analysis were performed to assess the prognostic relevance of gene expression of E-, N- and P-cadherin. Cox univariate analysis revealed that the decrease of E-cadherin and the gain of N-cadherin gene expression are risk factors for cancer-related death (P=0.087, P=0.005, respectively). Fourteen percent (13/92) of muscle-invasive bladder cancers were N-cadherin- negative. These patients had a significantly poorer prognosis than those with N-cadherin-positive muscle-invasive tumors (P=0.024). P-cadherin gene expression proved to be a significant independent prognostic factor for both cancer-specific and recurrence-free survival (P=0.011, P=0.036). The characteristic 'cadherin switch' between low- and high-stage tumors that we observed and the prognostic significance of E-, N- and P-cadherin suggests the importance of these markers in bladder cancer progression. The poor patient prognosis in N-cadherin-negative muscle-invasive tumors indicates an alternative, N-cadherin-independent way in bladder cancer progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204300     DOI: 10.3892/or_00000741

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  20 in total

Review 1.  Biomarkers for prognosis and treatment selection in advanced bladder cancer patients.

Authors:  Yuanbin Ru; Garrett M Dancik; Dan Theodorescu
Journal:  Curr Opin Urol       Date:  2011-09       Impact factor: 2.309

2.  Honokiol inhibits bladder cancer cell invasion through repressing SRC-3 expression and epithelial-mesenchymal transition.

Authors:  Lan Shen; Fang Zhang; Ruimin Huang; Jun Yan; Bing Shen
Journal:  Oncol Lett       Date:  2017-07-25       Impact factor: 2.967

3.  P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer.

Authors:  Lichao Sun; Hai Hu; Liang Peng; Zhuan Zhou; Xuan Zhao; Jian Pan; Lixin Sun; Zhihua Yang; Yuliang Ran
Journal:  Am J Pathol       Date:  2011-05-23       Impact factor: 4.307

4.  [Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?].

Authors:  T Szarvas; F Hoffmann; M Becker; M Schenck; F Vom Dorp; H Rübben; T Jäger
Journal:  Urologe A       Date:  2011-01       Impact factor: 0.639

Review 5.  Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.

Authors:  Tamara Severi; Hannah van Malenstein; Chris Verslype; Jos F van Pelt
Journal:  Acta Pharmacol Sin       Date:  2010-10-18       Impact factor: 6.150

6.  E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms.

Authors:  Mohit Kumar Jolly; Kathryn E Ware; Shengnan Xu; Shivee Gilja; Samantha Shetler; Yanjun Yang; Xueyang Wang; R Garland Austin; Daniella Runyambo; Alexander J Hish; Suzanne Bartholf DeWitt; Jason T George; R Timothy Kreulen; Mary-Keara Boss; Alexander L Lazarides; David L Kerr; Drew G Gerber; Dharshan Sivaraj; Andrew J Armstrong; Mark W Dewhirst; William C Eward; Herbert Levine; Jason A Somarelli
Journal:  Mol Cancer Res       Date:  2019-03-12       Impact factor: 5.852

Review 7.  [Identification of diagnostic tumour markers and therapeutic targets in testicular tumours].

Authors:  F Bremmer
Journal:  Pathologe       Date:  2018-12       Impact factor: 1.011

Review 8.  [Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research].

Authors:  C Bolenz; T Martini; M S Michel
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

9.  Mechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells.

Authors:  Ke-Hung Tsui; Shyi-Wu Wang; Li-Chuan Chung; Tsui-Hsia Feng; Tzu-Yi Lee; Phei-Lang Chang; Horng-Heng Juang
Journal:  Biomed Res Int       Date:  2013-05-16       Impact factor: 3.411

10.  Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene.

Authors:  T Okegawa; K Ushio; M Imai; M Morimoto; T Hara
Journal:  Oncogenesis       Date:  2013-07-29       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.